New data highlights value of Janssen's Spravato - PharmaTimes

Submitted by Anonymous (not verified) on Thu, 05/23/2019 - 09:03

New data highlights value of Janssen's Spravato  PharmaTimesThe approval of the drug is a new way of treating adults with TRD that is unlike other treatment options in psychiatry. - News - PharmaTimes.